184 related articles for article (PubMed ID: 24153116)
21. QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
Kim EJ; Kim JS; Lee S; Lee H; Yoon JS; Hong JH; Chun SH; Sun S; Won HS; Hong SA; Kang K; Jo JY; Choi M; Shin DH; Ahn YH; Ko YH
Int J Cancer; 2019 Sep; 145(6):1585-1595. PubMed ID: 31026342
[TBL] [Abstract][Full Text] [Related]
22. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
23. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer.
Xiong SW; Lin TX; Xu KW; Dong W; Ling XH; Jiang FN; Chen G; Zhong WD; Huang J
Pathol Oncol Res; 2013 Jul; 19(3):529-37. PubMed ID: 23456549
[TBL] [Abstract][Full Text] [Related]
25. Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells.
Fassan M; D'Arca D; Letko J; Vecchione A; Gardiman MP; McCue P; Wildemore B; Rugge M; Shupp-Byrne D; Gomella LG; Morrione A; Iozzo RV; Baffa R
PLoS One; 2011 May; 6(5):e19771. PubMed ID: 21573075
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor‑mediated upregulation of quaking affects androgen receptor‑related prostate cancer development and anti‑androgen receptor therapy.
Zhang K; Yan F; Lei X; Wei D; Lu H; Zhu Z; Xiang A; Ye Z; Wang L; Zheng W; Li X; Yuan J; Lu Z; Yuan J
Mol Med Rep; 2018 Jun; 17(6):8203-8211. PubMed ID: 29658587
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.
Prudnikova TY; Soulitzis N; Kutsenko OS; Mostovich LA; Haraldson K; Ernberg I; Kashuba VI; Spandidos DA; Zabarovsky ER; Grigorieva EV
Cancer Med; 2013 Oct; 2(5):654-61. PubMed ID: 24403231
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
[TBL] [Abstract][Full Text] [Related]
29. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing.
Zong FY; Fu X; Wei WJ; Luo YG; Heiner M; Cao LJ; Fang Z; Fang R; Lu D; Ji H; Hui J
PLoS Genet; 2014 Apr; 10(4):e1004289. PubMed ID: 24722255
[TBL] [Abstract][Full Text] [Related]
30. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.
Majid S; Dar AA; Saini S; Arora S; Shahryari V; Zaman MS; Chang I; Yamamura S; Tanaka Y; Deng G; Dahiya R
Cancer Res; 2012 Dec; 72(24):6435-46. PubMed ID: 23074286
[TBL] [Abstract][Full Text] [Related]
31. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
33. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
34. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
37. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
[TBL] [Abstract][Full Text] [Related]
38. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.
van der Veer EP; de Bruin RG; Kraaijeveld AO; de Vries MR; Bot I; Pera T; Segers FM; Trompet S; van Gils JM; Roeten MK; Beckers CM; van Santbrink PJ; Janssen A; van Solingen C; Swildens J; de Boer HC; Peters EA; Bijkerk R; Rousch M; Doop M; Kuiper J; Schalij MJ; van der Wal AC; Richard S; van Berkel TJ; Pickering JG; Hiemstra PS; Goumans MJ; Rabelink TJ; de Vries AA; Quax PH; Jukema JW; Biessen EA; van Zonneveld AJ
Circ Res; 2013 Oct; 113(9):1065-75. PubMed ID: 23963726
[TBL] [Abstract][Full Text] [Related]
39. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
[TBL] [Abstract][Full Text] [Related]
40. [LASS2/TMSG1 gene silencing promotes the invasiveness and metastatic of human prostatic carcinoma cells through increase in vacuolar ATPase activity].
Xu X; You J; Pei F
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):177-83. PubMed ID: 24842017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]